These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38272554)

  • 21. What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease? Development and validation of a survey for use in a secondary care screening setting.
    Willis K; Chaudhry UAR; Chandrasekaran L; Wahlich C; Olvera-Barrios A; Chambers R; Bolter L; Anderson J; Barman SA; Fajtl J; Welikala R; Egan C; Tufail A; Owen CG; Rudnicka A; ;
    BMJ Open; 2023 Nov; 13(11):e075558. PubMed ID: 37968006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of peer support to increase uptake of retinal examination for diabetic retinopathy: study protocol for the DURE pragmatic cluster randomized clinical trial in Kirinyaga, Kenya.
    Mwangi N; Ng'ang'a M; Gakuo E; Gichuhi S; Macleod D; Moorman C; Muthami L; Tum P; Jalango A; Githeko K; Gichangi M; Kibachio J; Bascaran C; Foster A
    BMC Public Health; 2018 Jul; 18(1):871. PubMed ID: 30005643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Using artificial intelligence as an initial triage strategy in diabetic retinopathy screening program in China].
    Li ZX; Zhang J; Fong N; He MG
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(48):3835-3840. PubMed ID: 33371627
    [No Abstract]   [Full Text] [Related]  

  • 24. Artificial intelligence-based screening for diabetic retinopathy at community hospital.
    He J; Cao T; Xu F; Wang S; Tao H; Wu T; Sun L; Chen J
    Eye (Lond); 2020 Mar; 34(3):572-576. PubMed ID: 31455902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth.
    Wolf RM; Liu TYA; Thomas C; Prichett L; Zimmer-Galler I; Smith K; Abramoff MD; Channa R
    Diabetes Care; 2021 Mar; 44(3):781-787. PubMed ID: 33479160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients.
    Heydon P; Egan C; Bolter L; Chambers R; Anderson J; Aldington S; Stratton IM; Scanlon PH; Webster L; Mann S; du Chemin A; Owen CG; Tufail A; Rudnicka AR
    Br J Ophthalmol; 2021 May; 105(5):723-728. PubMed ID: 32606081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Automated Grading System for Detection of Vision-Threatening Referable Diabetic Retinopathy on the Basis of Color Fundus Photographs.
    Li Z; Keel S; Liu C; He Y; Meng W; Scheetz J; Lee PY; Shaw J; Ting D; Wong TY; Taylor H; Chang R; He M
    Diabetes Care; 2018 Dec; 41(12):2509-2516. PubMed ID: 30275284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing and evaluating a fully functional AI-enabled model for chronic eye disease screening in a real clinical environment.
    Skevas C; de Olaguer NP; Lleó A; Thiwa D; Schroeter U; Lopes IV; Mautone L; Linke SJ; Spitzer MS; Yap D; Xiao D
    BMC Ophthalmol; 2024 Feb; 24(1):51. PubMed ID: 38302908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic test accuracy of diabetic retinopathy screening by physician graders using a hand-held non-mydriatic retinal camera at a tertiary level medical clinic.
    Piyasena MMPN; Yip JLY; MacLeod D; Kim M; Gudlavalleti VSM
    BMC Ophthalmol; 2019 Apr; 19(1):89. PubMed ID: 30961576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application.
    Piatti A; Romeo F; Manti R; Doglio M; Tartaglino B; Nada E; Giorda CB
    Acta Diabetol; 2024 Jan; 61(1):63-68. PubMed ID: 37676288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teleophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease (HERMES): a Cluster Randomised Superiority Trial with a linked Diagnostic Accuracy Study-HERMES study report 1-study protocol.
    Han JED; Liu X; Bunce C; Douiri A; Vale L; Blandford A; Lawrenson J; Hussain R; Grimaldi G; Learoyd AE; Kernohan A; Dinah C; Minos E; Sim D; Aslam T; Patel PJ; Denniston AK; Keane PA; Balaskas K
    BMJ Open; 2022 Feb; 12(2):e055845. PubMed ID: 35105593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of Artificial Intelligence Algorithm in the Detection and Staging of Diabetic Retinopathy through Fundus Photography: An Automated Tool for Detection and Grading of Diabetic Retinopathy.
    Pawar B; Lobo SN; Joseph M; Jegannathan S; Jayraj H
    Middle East Afr J Ophthalmol; 2021; 28(2):81-86. PubMed ID: 34759664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.
    Ipp E; Liljenquist D; Bode B; Shah VN; Silverstein S; Regillo CD; Lim JI; Sadda S; Domalpally A; Gray G; Bhaskaranand M; Ramachandra C; Solanki K;
    JAMA Netw Open; 2021 Nov; 4(11):e2134254. PubMed ID: 34779843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Artificial Intelligence Algorithms for Diabetic Retinopathy Detection: Protocol for a Systematic Review and Meta-Analysis.
    Sesgundo Iii JA; Maeng DC; Tukay JA; Ascano MP; Suba-Cohen J; Sampang V
    JMIR Res Protoc; 2024 May; 13():e57292. PubMed ID: 38801771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening.
    Xie Y; Gunasekeran DV; Balaskas K; Keane PA; Sim DA; Bachmann LM; Macrae C; Ting DSW
    Transl Vis Sci Technol; 2020 Apr; 9(2):22. PubMed ID: 32818083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement.
    Raman R; Ramasamy K; Rajalakshmi R; Sivaprasad S; Natarajan S
    Indian J Ophthalmol; 2021 Mar; 69(3):678-688. PubMed ID: 33269742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telemedical Diabetic Retinopathy Screening in a Primary Care Setting: Quality of Retinal Photographs and Accuracy of Automated Image Analysis.
    Wintergerst MWM; Bejan V; Hartmann V; Schnorrenberg M; Bleckwenn M; Weckbecker K; Finger RP
    Ophthalmic Epidemiol; 2022 Jun; 29(3):286-295. PubMed ID: 34151725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.